PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,846,452 | -27.1% | 5,446,430 | +20.7% | 0.46% | -29.7% |
| Q2 2023 | $124,605,697 | +107.2% | 4,511,430 | +72.5% | 0.65% | +94.3% |
| Q1 2023 | $60,145,322 | +51.0% | 2,615,014 | -28.4% | 0.33% | +39.9% |
| Q4 2022 | $39,842,087 | +29.4% | 3,651,887 | 0.0% | 0.24% | +40.0% |
| Q3 2022 | $30,785,000 | +5.2% | 3,651,887 | -1.3% | 0.17% | +6.2% |
| Q2 2022 | $29,272,000 | +9.0% | 3,700,608 | +226.2% | 0.16% | +23.1% |
| Q1 2022 | $26,864,000 | -59.0% | 1,134,457 | -40.8% | 0.13% | -60.2% |
| Q4 2021 | $65,566,000 | +54.7% | 1,917,134 | -19.9% | 0.33% | +65.2% |
| Q3 2021 | $42,386,000 | -59.5% | 2,392,000 | +2.7% | 0.20% | -53.6% |
| Q2 2021 | $104,556,000 | +66.5% | 2,329,680 | -3.9% | 0.43% | +36.9% |
| Q1 2021 | $62,808,000 | +28.5% | 2,425,000 | 0.0% | 0.31% | +6.1% |
| Q4 2020 | $48,888,000 | -9.1% | 2,425,000 | -11.8% | 0.29% | -21.0% |
| Q3 2020 | $53,763,000 | +21.8% | 2,750,000 | +10.0% | 0.37% | +5.4% |
| Q2 2020 | $44,150,000 | +316.9% | 2,500,000 | +66.7% | 0.35% | +287.9% |
| Q1 2020 | $10,590,000 | +0.1% | 1,500,000 | 0.0% | 0.09% | +28.2% |
| Q4 2019 | $10,575,000 | -41.3% | 1,500,000 | 0.0% | 0.07% | -47.8% |
| Q3 2019 | $18,015,000 | -0.8% | 1,500,000 | 0.0% | 0.14% | +15.3% |
| Q2 2019 | $18,165,000 | -19.3% | 1,500,000 | -16.2% | 0.12% | -30.2% |
| Q1 2019 | $22,500,000 | +52.0% | 1,790,000 | -18.6% | 0.17% | +55.0% |
| Q4 2018 | $14,804,000 | -35.9% | 2,199,674 | -1.9% | 0.11% | -19.9% |
| Q3 2018 | $23,083,000 | +277.4% | 2,243,202 | +146.4% | 0.14% | +257.9% |
| Q2 2018 | $6,117,000 | -29.7% | 910,229 | -10.2% | 0.04% | -36.7% |
| Q1 2018 | $8,706,000 | -53.5% | 1,013,500 | +12.6% | 0.06% | -60.5% |
| Q4 2017 | $18,720,000 | – | 900,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |